| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70377-067-11 | 70377-067 | HUMAN PRESCRIPTION DRUG | Prazosin hydrochloride | Prazosin hydrochloride | CAPSULE | ORAL | 20230109 | N/A | ANDA | ANDA213406 | Biocon Pharma Inc. | PRAZOSIN HYDROCHLORIDE | 2 mg/1 | 100 CAPSULE in 1 BOTTLE (70377-067-11) |
| 70377-068-11 | 70377-068 | HUMAN PRESCRIPTION DRUG | Prazosin hydrochloride | Prazosin hydrochloride | CAPSULE | ORAL | 20230109 | N/A | ANDA | ANDA213406 | Biocon Pharma Inc. | PRAZOSIN HYDROCHLORIDE | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (70377-068-11) |
| 70518-3928-0 | 70518-3928 | HUMAN PRESCRIPTION DRUG | Prazosin hydrochloride | Prazosin hydrochloride | CAPSULE | ORAL | 20231129 | N/A | ANDA | ANDA213406 | REMEDYREPACK INC. | PRAZOSIN HYDROCHLORIDE | 1 mg/1 | 30 CAPSULE in 1 BLISTER PACK (70518-3928-0) |
| 70377-066-11 | 70377-066 | HUMAN PRESCRIPTION DRUG | Prazosin hydrochloride | Prazosin hydrochloride | CAPSULE | ORAL | 20230109 | N/A | ANDA | ANDA213406 | Biocon Pharma Inc. | PRAZOSIN HYDROCHLORIDE | 1 mg/1 | 100 CAPSULE in 1 BOTTLE (70377-066-11) |